Cognition Improvement by Oral Huperzine A: A Novel Acetylcholinesterase Inhibitor
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
1982 • 3,563 citations
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
1983 • 3,028 citations
Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type
1986 • 1,148 citations
The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity
1986 • 453 citations
Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspects
1988 • 196 citations
Cholinergic Basis for Alzheimer Therapy
1991 • 177 citations
Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat
1989 • 139 citations
Step-down-type passive avoidance- and escape-learning method
1986 • 127 citations
Efficacy of oral physostigmine in primary degenerative dementia
1985 • 97 citations
The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat
1989 • 85 citations
[Anti-cholinesterase activity of huperzine A].
1986 • 75 citations
[Drug evaluation of huperzine A in the treatment of senile memory disorders].
1991 • 70 citations
Present state and future development of the therapy of Alzheimer disease
1990 • 44 citations
The Second Generation of Cholinesterase Inhibitors: Pharmacological Aspects
1991 • 37 citations
Therapeutic effects of huperzine A on the aged with memory impairment
1986 • 18 citations
Current Research in Alzheimer Therapy
1990 • 17 citations
[Pharmacokinetics of huperzine A in rats and mice].
1988 • 16 citations
Cited By (0)
No citing papers found in database